glp-1 microdosing research Micro Dosing After 50...? An ER Doctor Explains Microdosing GLP-1s could help telehealth

Frequency sweep measurements were performed at 5% strain and a frequency range of 500 to 0.1 rad s 1

A random-effects meta-analysis yielded a pooled odds ratio (OR) of 1.49 (95% CI 1.181.88), indicating a 49% relative increase in the risk of depression-related outcomes among GLP-1 RA users compared with controls (Fig

Toxin cleavage may enhance cell-binding and/or translocation, stabilization or catalytic activity of the toxic moiety specifically in protease expressing cells, leading to their suppression

The FDA also required changes to the labels to achieve a more uniform presentation of side effects and risk information for all of the drugs in the GLP-1 category, including adding or changing subsections for Acute Pancreatitis and Severe Gastrointestinal Adverse Reactions and revising the Patient Counseling section and Medication Guide. Some of the labels were also updated with post-marketing reports of hair loss (alopecia) and the neurological symptom of altered sense of touch, or dysethesia

These findings highlight its dual benefits for both cognition and mood